Phase 1 Trial to Test BDNF Gene Therapy in Alzheimer’s Patients
News
A Phase 1 trial will evaluate the use of gene therapy in delivering brain-derived neurotrophic factor (BDNF) to the brains of people with Alzheimer’s disease or mild cognitive impairment ... Read more